539997 KWALITY

Kwality Pharmaceuticals Share Price

 

Stock touched all time high

 

Start SIP in KWALITY

Start SIP

Performance

  • Low
  • ₹1,321
  • High
  • ₹1,428
  • 52 Week Low
  • ₹596
  • 52 Week High
  • ₹1,428
  • Open Price₹1,388
  • Previous Close₹1,362
  • Volume113,752
  • 50 DMA₹1,080.84
  • 100 DMA₹1,033.67
  • 200 DMA₹978.78

Investment Returns

  • Over 1 Month + 27.93%
  • Over 3 Month + 59.02%
  • Over 6 Month + 31.8%
  • Over 1 Year + 80.11%

Smart Investing Starts Here Start SIP with Kwality Pharmaceuticals for Steady Growth!

Invest Now

Kwality Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 26
  • PEG Ratio
  • 0.3
  • Market Cap Cr
  • 1,468
  • P/B Ratio
  • 5.1
  • Average True Range
  • 71.78
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 24.95
  • RSI
  • 73.36
  • MFI
  • 79.96

Kwality Pharmaceuticals Financials

Kwality Pharmaceuticals Technicals

EMA & SMA

Current Price
₹1,415.00
+ 53 (3.89%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹1,139.23
  • 50 Day
  • ₹1,080.84
  • 100 Day
  • ₹1,033.67
  • 200 Day
  • ₹978.78

Resistance and Support

1296.33 Pivot Speed
  • R3 1,669.67
  • R2 1,523.33
  • R1 1,442.67
  • S1 1,215.67
  • S2 1,069.33
  • S3 988.67

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Kwality Pharmaceuticals has an operating revenue of Rs. 422.61 Cr. on a trailing 12-month basis. An annual revenue growth of 20% is outstanding, Pre-tax margin of 15% is great, ROE of 15% is good. The company has a reasonable debt to equity of 6%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 8% and 15% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 13% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 61 which is a FAIR score but needs to improve its earnings, a RS Rating of 94 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 78 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of A is the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Kwality Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-12 Quarterly Results
2025-11-13 Quarterly Results
2025-08-11 Quarterly Results
2025-05-19 Audited Results
2025-01-31 Quarterly Results

Kwality Pharmaceuticals F&O

Kwality Pharmaceuticals Shareholding Pattern

54.83%
0%
0.5%
33.02%
11.65%

About Kwality Pharmaceuticals

  • NSE Symbol
  • KWALITY
  • BSE Symbol
  • 539997
  • Managing Director
  • Mr. Ramesh Arora
  • ISIN
  • INE552U01010

Similar Stocks to Kwality Pharmaceuticals

Kwality Pharmaceuticals FAQs

Kwality Pharmaceuticals share price is ₹1,415 As on 13 February, 2026 | 12:15

The Market Cap of Kwality Pharmaceuticals is ₹1468.2 Cr As on 13 February, 2026 | 12:15

The P/E ratio of Kwality Pharmaceuticals is 26 As on 13 February, 2026 | 12:15

The PB ratio of Kwality Pharmaceuticals is 5.1 As on 13 February, 2026 | 12:15

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23